{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:07:53Z","timestamp":1790996873823,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejpb.2016.07.026","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:32:52Z","timestamp":1470789172000},"page":"253-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["Nanostructured lipid carriers for the topical delivery of tretinoin"],"prefix":"10.1016","volume":"108","author":[{"given":"Vivek M.","family":"Ghate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaila A.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhakara","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2016.07.026_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.12.005","article-title":"Lipid vesicles for skin delivery of drugs: reviewing three decades of research","volume":"332","author":"Elsayed","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.026_b0010","first-page":"375","article-title":"Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems","volume":"61","author":"Uner","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejpb.2016.07.026_b0015","first-page":"705","article-title":"Nano structured lipid carriers: a novel topical drug delivery system","volume":"4","author":"Dubey","year":"2012","journal-title":"Int. J. PharmTech Res."},{"key":"10.1016\/j.ejpb.2016.07.026_b0020","series-title":"Adv. Drug Deliv. Rev.","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations","author":"M\u00fcller","year":"2002"},{"key":"10.1016\/j.ejpb.2016.07.026_b0025","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3109\/1061186X.2012.716845","article-title":"Nanostructured lipid carriers system: recent advances in drug delivery","volume":"20","author":"Iqbal","year":"2012","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ejpb.2016.07.026_b0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","volume":"366","author":"Pardeike","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.026_b0035","first-page":"393","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) \u2013 structural investigations on two different carrier systems","volume":"15","author":"Saupe","year":"2005","journal-title":"Biomed. Mater. Eng."},{"key":"10.1016\/j.ejpb.2016.07.026_b0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1468-2494.2008.00433.x","article-title":"Cosmetic features and applications of lipid nanoparticles (SLN, NLC)","volume":"30","author":"Souto","year":"2008","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.ejpb.2016.07.026_b0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1461-5347(00)00255-8","article-title":"Therapeutic applications of colloidal drug carriers","volume":"3","author":"Barratt","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.ejpb.2016.07.026_b0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1476-511X-11-159","article-title":"Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy","volume":"11","author":"Selvamuthukumar","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejpb.2016.07.026_b0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2008.07.017","article-title":"A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers","volume":"363","author":"Li","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.026_b0060","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1208\/s12249-010-9553-2","article-title":"Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)","volume":"11","author":"Sanad","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2016.07.026_b0065","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40089-015-0161-8","article-title":"Development of nanostructured lipid carrier for dacarbazine delivery","volume":"5","author":"Almousallam","year":"2015","journal-title":"Int. Nano Lett."},{"key":"10.1016\/j.ejpb.2016.07.026_b0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2147\/ciia.2006.1.4.327","article-title":"Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety","volume":"1","author":"Mukherjee","year":"2006","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.ejpb.2016.07.026_b0075","first-page":"64","article-title":"A randomized, double-blind, controlled comparative trial of the anti-aging properties of non-prescription tri-retinol 1.1% vs. prescription tretinoin 0.025%","volume":"11","author":"Ho","year":"2012","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.ejpb.2016.07.026_b0080","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/BF02505289","article-title":"Regulation of keratinocyte proliferation and differentiation by all-trans-retinoic acid, 9-cis-retinoic acid and 1,25-dihydroxy vitamin D3","volume":"288","author":"Gibbs","year":"1996","journal-title":"Arch. Dermatol. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.ejpb.2016.07.026_b0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-0625.12.s2.6.x","article-title":"Tretinoin reverses upregulation of matrix metalloproteinase-13 in human keloid-derived fibroblasts","volume":"12","author":"Uchida","year":"2003","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejpb.2016.07.026_b0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3177\/jnsv.58.223","article-title":"The effects of vitamin A compounds on hyaluronic acid released from cultured rabbit corneal epithelial cells and keratocytes","volume":"58","author":"Toshida","year":"2012","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.ejpb.2016.07.026_b0095","doi-asserted-by":"crossref","DOI":"10.4161\/derm.22804","article-title":"Skin antiaging strategies","volume":"4","author":"Ganceviciene","year":"2012","journal-title":"Dermatoendocrinology"},{"key":"10.1016\/j.ejpb.2016.07.026_b0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2133.2009.09436.x","article-title":"A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide\/peptide\/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen","volume":"162","author":"Fu","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2016.07.026_b0105","first-page":"466","article-title":"Evaluating tretinoin formulations in the treatment of acne","volume":"13","author":"Kircik","year":"2014","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.ejpb.2016.07.026_b0110","article-title":"Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing","volume":"3","author":"Rendon","year":"2010","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.ejpb.2016.07.026_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/acph-2015-0009","article-title":"Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery","volume":"65","author":"Gonullu","year":"2015","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejpb.2016.07.026_b0120","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1002\/jps.22711","article-title":"Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers","volume":"100","author":"Kasongo","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.07.026_b0125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.colsurfa.2009.11.006","article-title":"Optimization of nanostructured lipid carriers for lutein delivery","volume":"353","author":"Liu","year":"2010","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ejpb.2016.07.026_b0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2015.07.013","article-title":"Optimization of nanostructured lipid carriers loaded with methotrexate: a tool for inflammatory and cancer therapy","volume":"492","author":"Ferreira","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.026_b0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jsps.2012.11.005","article-title":"Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia","volume":"21","author":"Uprit","year":"2013","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ejpb.2016.07.026_b0140","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1208\/s12249-011-9665-3","article-title":"Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine","volume":"12","author":"Li","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2016.07.026_b0145","first-page":"773","article-title":"Influence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulation","volume":"60","author":"Laso\u0144","year":"2013","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ejpb.2016.07.026_b0150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3797\/scipharm.1202-12","article-title":"Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization, and in vivo evaluation","volume":"80","author":"Patel","year":"2012","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.026_b0155","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ijpharm.2013.03.034","article-title":"Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization","volume":"454","author":"Shete","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.026_b0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejps.2012.05.010","article-title":"Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?","volume":"47","author":"Das","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.07.026_b0165","first-page":"304","article-title":"Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine","volume":"67","author":"Zhou","year":"2012","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejpb.2016.07.026_b0170","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.lfs.2013.09.027","article-title":"Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam","volume":"93","author":"Khurana","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2016.07.026_b0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bfopcu.2015.10.001","article-title":"Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride","volume":"53","author":"Gaba","year":"2015","journal-title":"Bull. Fac. Pharm., Cairo Univ."},{"key":"10.1016\/j.ejpb.2016.07.026_b0180","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jconrel.2012.05.011","article-title":"Enhanced skin permeation using polyarginine modified nanostructured lipid carriers","volume":"161","author":"Shah","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.07.026_b0185","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/0019-5154.135489","article-title":"Delivery of amphotericin B for effective treatment of candida albicans induced dermal mycosis in rats via Emulgel system: formulation and evaluation","volume":"59","author":"Ganeshpurkar","year":"2014","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.ejpb.2016.07.026_b0190","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/03639040701842485","article-title":"Development of nitrendipine controlled release formulations based on SLN and NLC for topical delivery: in vitro and ex vivo characterization","volume":"34","author":"Bhaskar","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.026_b0195","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/0976-4836.72328","article-title":"Development and evaluation of formulations of microbial biotransformed extract of tobacco leaves for hair growth potential","volume":"2","author":"Murkute","year":"2010","journal-title":"Pharmacogn. Res."},{"key":"10.1016\/j.ejpb.2016.07.026_b0200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejps.2013.09.023","article-title":"Evaluation of nanostructured lipid carriers (NLC) and nanoemulsions as carriers for UV-filters: characterization, in vitro penetration and photostability studies","volume":"51","author":"Puglia","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.07.026_b0205","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijpharm.2012.08.040","article-title":"Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation","volume":"439","author":"Han","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.026_b0210","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jconrel.2004.01.005","article-title":"Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles","volume":"95","author":"Venkateswarlu","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.07.026_b0215","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1081\/DDC-100108370","article-title":"Release kinetics of acyclovir from a suspension of acyclovir incorporated in a cubic phase delivery system","volume":"27","author":"Helledi","year":"2001","journal-title":"Drug Dev. Ind. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116303861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116303861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T09:53:19Z","timestamp":1536486799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116303861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":43,"alternative-id":["S0939641116303861"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.07.026","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanostructured lipid carriers for the topical delivery of tretinoin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}